aluates Reports

$ 0.0

Automative

Global Phage Therapy Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-37B12844

Global Phage Therapy Market Research Report 2023

BUY CHAPTERS

Global Phage Therapy Market Research Report 2024

Code: QYRE-Auto-37B12844

Report

March 2024

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Phage Therapy Market Size

The global Phage Therapy market was valued at US$ 32 million in 2023 and is anticipated to reach US$ 100.8 million by 2030, witnessing a CAGR of 17.6% during the forecast period 2024-2030.

Phage Therapy Market

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.

This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy.

Report Scope

The Phage Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Phage Therapy Market Report

Report Metric	Details
Report Name	Phage Therapy Market
Accounted market size in 2023	US$ 32 million
Forecasted market size in 2030	US$ 100.8 million
CAGR	17.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	DsDNA Bacteriophage SsDNA Bacteriophage SsRNA Bacteriophage Others
Segment by Application	Animal Health Aquaculture Agriculture Food Industry Human Health Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Phage Therapy Market growing?

Ans: The Phage Therapy Market witnessing a CAGR of 17.6% during the forecast period 2024-2030.

What is the Phage Therapy Market size in 2030?

Ans: The Phage Therapy Market size in 2030 will be US$ 100.8 million.

What is the market share of major companies in Phage Therapy Market?

Ans: The top 3 players occupy about 25% shares of the global market.

What is the Phage Therapy Market share by type?

Ans: DsDNA Bacteriophage is the main type, with a share over 90%.

What is the Phage Therapy Market share by application?

Ans: Animal Health is the main application, which holds a share about 55%.

Who are the main players in the Phage Therapy Market report?

Ans: The main players in the Phage Therapy Market are NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS), Qingdao Phagepharm Bio-tech, Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage, Adaptive Phage Therapeutics, TechnoPhage

What are the Application segmentation covered in the Phage Therapy Market report?

Ans: The Applications covered in the Phage Therapy Market report are Animal Health, Aquaculture, Agriculture, Food Industry, Human Health, Others

What are the Type segmentation covered in the Phage Therapy Market report?

Ans: The Types covered in the Phage Therapy Market report are DsDNA Bacteriophage, SsDNA Bacteriophage, SsRNA Bacteriophage, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 DsDNA Bacteriophage

1.2.3 SsDNA Bacteriophage

1.2.4 SsRNA Bacteriophage

1.2.5 Others

1.3 Market by Application

1.3.1 Global Phage Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Animal Health

1.3.3 Aquaculture

1.3.4 Agriculture

1.3.5 Food Industry

1.3.6 Human Health

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Phage Therapy Market Perspective (2019-2030)

2.2 Phage Therapy Growth Trends by Region

2.2.1 Global Phage Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Phage Therapy Historic Market Size by Region (2019-2024)

2.2.3 Phage Therapy Forecasted Market Size by Region (2025-2030)

2.3 Phage Therapy Market Dynamics

2.3.1 Phage Therapy Industry Trends

2.3.2 Phage Therapy Market Drivers

2.3.3 Phage Therapy Market Challenges

2.3.4 Phage Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Phage Therapy Players by Revenue

3.1.1 Global Top Phage Therapy Players by Revenue (2019-2024)

3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Phage Therapy Revenue

3.4 Global Phage Therapy Market Concentration Ratio

3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2023

3.5 Phage Therapy Key Players Head office and Area Served

3.6 Key Players Phage Therapy Product Solution and Service

3.7 Date of Enter into Phage Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Phage Therapy Breakdown Data by Type

4.1 Global Phage Therapy Historic Market Size by Type (2019-2024)

4.2 Global Phage Therapy Forecasted Market Size by Type (2025-2030)

5 Phage Therapy Breakdown Data by Application

5.1 Global Phage Therapy Historic Market Size by Application (2019-2024)

5.2 Global Phage Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Phage Therapy Market Size (2019-2030)

6.2 North America Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Phage Therapy Market Size by Country (2019-2024)

6.4 North America Phage Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Phage Therapy Market Size (2019-2030)

7.2 Europe Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Phage Therapy Market Size by Country (2019-2024)

7.4 Europe Phage Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Phage Therapy Market Size (2019-2030)

8.2 Asia-Pacific Phage Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Phage Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Phage Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Phage Therapy Market Size (2019-2030)

9.2 Latin America Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Phage Therapy Market Size by Country (2019-2024)

9.4 Latin America Phage Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Phage Therapy Market Size (2019-2030)

10.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Phage Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Phage Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 NPO Microgen

11.1.1 NPO Microgen Company Detail

11.1.2 NPO Microgen Business Overview

11.1.3 NPO Microgen Phage Therapy Introduction

11.1.4 NPO Microgen Revenue in Phage Therapy Business (2019-2024)

11.1.5 NPO Microgen Recent Development

11.2 Proteon Pharmaceuticals

11.2.1 Proteon Pharmaceuticals Company Detail

11.2.2 Proteon Pharmaceuticals Business Overview

11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction

11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2019-2024)

11.2.5 Proteon Pharmaceuticals Recent Development

11.3 Phagelux

11.3.1 Phagelux Company Detail

11.3.2 Phagelux Business Overview

11.3.3 Phagelux Phage Therapy Introduction

11.3.4 Phagelux Revenue in Phage Therapy Business (2019-2024)

11.3.5 Phagelux Recent Development

11.4 Intralytix

11.4.1 Intralytix Company Detail

11.4.2 Intralytix Business Overview

11.4.3 Intralytix Phage Therapy Introduction

11.4.4 Intralytix Revenue in Phage Therapy Business (2019-2024)

11.4.5 Intralytix Recent Development

11.5 Micreos

11.5.1 Micreos Company Detail

11.5.2 Micreos Business Overview

11.5.3 Micreos Phage Therapy Introduction

11.5.4 Micreos Revenue in Phage Therapy Business (2019-2024)

11.5.5 Micreos Recent Development

11.6 Eliava BioPreparations

11.6.1 Eliava BioPreparations Company Detail

11.6.2 Eliava BioPreparations Business Overview

11.6.3 Eliava BioPreparations Phage Therapy Introduction

11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2019-2024)

11.6.5 Eliava BioPreparations Recent Development

11.7 Locus Biosciences,Inc

11.7.1 Locus Biosciences,Inc Company Detail

11.7.2 Locus Biosciences,Inc Business Overview

11.7.3 Locus Biosciences,Inc Phage Therapy Introduction

11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2019-2024)

11.7.5 Locus Biosciences,Inc Recent Development

11.8 Pharmex Group,LLC

11.8.1 Pharmex Group,LLC Company Detail

11.8.2 Pharmex Group,LLC Business Overview

11.8.3 Pharmex Group,LLC Phage Therapy Introduction

11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2019-2024)

11.8.5 Pharmex Group,LLC Recent Development

11.9 Pherecydes Pharma

11.9.1 Pherecydes Pharma Company Detail

11.9.2 Pherecydes Pharma Business Overview

11.9.3 Pherecydes Pharma Phage Therapy Introduction

11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2019-2024)

11.9.5 Pherecydes Pharma Recent Development

11.10 APS Biocontrol Ltd. (APS)

11.10.1 APS Biocontrol Ltd. (APS) Company Detail

11.10.2 APS Biocontrol Ltd. (APS) Business Overview

11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction

11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2019-2024)

11.10.5 APS Biocontrol Ltd. (APS) Recent Development

11.11 Qingdao Phagepharm Bio-tech

11.11.1 Qingdao Phagepharm Bio-tech Company Detail

11.11.2 Qingdao Phagepharm Bio-tech Business Overview

11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction

11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2019-2024)

11.11.5 Qingdao Phagepharm Bio-tech Recent Development

11.12 Fixed-Phage Limited

11.12.1 Fixed-Phage Limited Company Detail

11.12.2 Fixed-Phage Limited Business Overview

11.12.3 Fixed-Phage Limited Phage Therapy Introduction

11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2019-2024)

11.12.5 Fixed-Phage Limited Recent Development

11.13 Zeptometrix

11.13.1 Zeptometrix Company Detail

11.13.2 Zeptometrix Business Overview

11.13.3 Zeptometrix Phage Therapy Introduction

11.13.4 Zeptometrix Revenue in Phage Therapy Business (2019-2024)

11.13.5 Zeptometrix Recent Development

11.14 Phage International, Inc.

11.14.1 Phage International, Inc. Company Detail

11.14.2 Phage International, Inc. Business Overview

11.14.3 Phage International, Inc. Phage Therapy Introduction

11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2019-2024)

11.14.5 Phage International, Inc. Recent Development

11.15 MicroMir

11.15.1 MicroMir Company Detail

11.15.2 MicroMir Business Overview

11.15.3 MicroMir Phage Therapy Introduction

11.15.4 MicroMir Revenue in Phage Therapy Business (2019-2024)

11.15.5 MicroMir Recent Development

11.16 iNtODEWORLD, Inc.

11.16.1 iNtODEWORLD, Inc. Company Detail

11.16.2 iNtODEWORLD, Inc. Business Overview

11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction

11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2019-2024)

11.16.5 iNtODEWORLD, Inc. Recent Development

11.17 NEXTBIOTICS

11.17.1 NEXTBIOTICS Company Detail

11.17.2 NEXTBIOTICS Business Overview

11.17.3 NEXTBIOTICS Phage Therapy Introduction

11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2019-2024)

11.17.5 NEXTBIOTICS Recent Development

11.18 Armata Pharmaceuticals, Inc.

11.18.1 Armata Pharmaceuticals, Inc. Company Detail

11.18.2 Armata Pharmaceuticals, Inc. Business Overview

11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction

11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2019-2024)

11.18.5 Armata Pharmaceuticals, Inc. Recent Development

11.19 Innophage

11.19.1 Innophage Company Detail

11.19.2 Innophage Business Overview

11.19.3 Innophage Phage Therapy Introduction

11.19.4 Innophage Revenue in Phage Therapy Business (2019-2024)

11.19.5 Innophage Recent Development

11.20 Adaptive Phage Therapeutics

11.20.1 Adaptive Phage Therapeutics Company Detail

11.20.2 Adaptive Phage Therapeutics Business Overview

11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction

11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2019-2024)

11.20.5 Adaptive Phage Therapeutics Recent Development

11.21 TechnoPhage

11.21.1 TechnoPhage Company Detail

11.21.2 TechnoPhage Business Overview

11.21.3 TechnoPhage Phage Therapy Introduction

11.21.4 TechnoPhage Revenue in Phage Therapy Business (2019-2024)

11.21.5 TechnoPhage Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of DsDNA Bacteriophage

Table 3. Key Players of SsDNA Bacteriophage

Table 4. Key Players of SsRNA Bacteriophage

Table 5. Key Players of Others

Table 6. Global Phage Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Phage Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Phage Therapy Market Share by Region (2019-2024)

Table 10. Global Phage Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Phage Therapy Market Share by Region (2025-2030)

Table 12. Phage Therapy Market Trends

Table 13. Phage Therapy Market Drivers

Table 14. Phage Therapy Market Challenges

Table 15. Phage Therapy Market Restraints

Table 16. Global Phage Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Phage Therapy Market Share by Players (2019-2024)

Table 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2023)

Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Phage Therapy Product Solution and Service

Table 23. Date of Enter into Phage Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Phage Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Phage Therapy Revenue Market Share by Type (2019-2024)

Table 27. Global Phage Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Phage Therapy Revenue Market Share by Type (2025-2030)

Table 29. Global Phage Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Phage Therapy Revenue Market Share by Application (2019-2024)

Table 31. Global Phage Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Phage Therapy Revenue Market Share by Application (2025-2030)

Table 33. North America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Phage Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Phage Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Phage Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Phage Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Phage Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Phage Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Phage Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Phage Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Phage Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Phage Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Phage Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Phage Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. NPO Microgen Company Detail

Table 49. NPO Microgen Business Overview

Table 50. NPO Microgen Phage Therapy Product

Table 51. NPO Microgen Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 52. NPO Microgen Recent Development

Table 53. Proteon Pharmaceuticals Company Detail

Table 54. Proteon Pharmaceuticals Business Overview

Table 55. Proteon Pharmaceuticals Phage Therapy Product

Table 56. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 57. Proteon Pharmaceuticals Recent Development

Table 58. Phagelux Company Detail

Table 59. Phagelux Business Overview

Table 60. Phagelux Phage Therapy Product

Table 61. Phagelux Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 62. Phagelux Recent Development

Table 63. Intralytix Company Detail

Table 64. Intralytix Business Overview

Table 65. Intralytix Phage Therapy Product

Table 66. Intralytix Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 67. Intralytix Recent Development

Table 68. Micreos Company Detail

Table 69. Micreos Business Overview

Table 70. Micreos Phage Therapy Product

Table 71. Micreos Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 72. Micreos Recent Development

Table 73. Eliava BioPreparations Company Detail

Table 74. Eliava BioPreparations Business Overview

Table 75. Eliava BioPreparations Phage Therapy Product

Table 76. Eliava BioPreparations Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 77. Eliava BioPreparations Recent Development

Table 78. Locus Biosciences,Inc Company Detail

Table 79. Locus Biosciences,Inc Business Overview

Table 80. Locus Biosciences,Inc Phage Therapy Product

Table 81. Locus Biosciences,Inc Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 82. Locus Biosciences,Inc Recent Development

Table 83. Pharmex Group,LLC Company Detail

Table 84. Pharmex Group,LLC Business Overview

Table 85. Pharmex Group,LLC Phage Therapy Product

Table 86. Pharmex Group,LLC Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 87. Pharmex Group,LLC Recent Development

Table 88. Pherecydes Pharma Company Detail

Table 89. Pherecydes Pharma Business Overview

Table 90. Pherecydes Pharma Phage Therapy Product

Table 91. Pherecydes Pharma Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 92. Pherecydes Pharma Recent Development

Table 93. APS Biocontrol Ltd. (APS) Company Detail

Table 94. APS Biocontrol Ltd. (APS) Business Overview

Table 95. APS Biocontrol Ltd. (APS) Phage Therapy Product

Table 96. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 97. APS Biocontrol Ltd. (APS) Recent Development

Table 98. Qingdao Phagepharm Bio-tech Company Detail

Table 99. Qingdao Phagepharm Bio-tech Business Overview

Table 100. Qingdao Phagepharm Bio-tech Phage Therapy Product

Table 101. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 102. Qingdao Phagepharm Bio-tech Recent Development

Table 103. Fixed-Phage Limited Company Detail

Table 104. Fixed-Phage Limited Business Overview

Table 105. Fixed-Phage Limited Phage Therapy Product

Table 106. Fixed-Phage Limited Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 107. Fixed-Phage Limited Recent Development

Table 108. Zeptometrix Company Detail

Table 109. Zeptometrix Business Overview

Table 110. Zeptometrix Phage Therapy Product

Table 111. Zeptometrix Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 112. Zeptometrix Recent Development

Table 113. Phage International, Inc. Company Detail

Table 114. Phage International, Inc. Business Overview

Table 115. Phage International, Inc. Phage Therapy Product

Table 116. Phage International, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 117. Phage International, Inc. Recent Development

Table 118. MicroMir Company Detail

Table 119. MicroMir Business Overview

Table 120. MicroMir Phage Therapy Product

Table 121. MicroMir Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 122. MicroMir Recent Development

Table 123. iNtODEWORLD, Inc. Company Detail

Table 124. iNtODEWORLD, Inc. Business Overview

Table 125. iNtODEWORLD, Inc. Phage Therapy Product

Table 126. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 127. iNtODEWORLD, Inc. Recent Development

Table 128. NEXTBIOTICS Company Detail

Table 129. NEXTBIOTICS Business Overview

Table 130. NEXTBIOTICS Phage Therapy Product

Table 131. NEXTBIOTICS Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 132. NEXTBIOTICS Recent Development

Table 133. Armata Pharmaceuticals, Inc. Company Detail

Table 134. Armata Pharmaceuticals, Inc. Business Overview

Table 135. Armata Pharmaceuticals, Inc. Phage Therapy Product

Table 136. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 137. Armata Pharmaceuticals, Inc. Recent Development

Table 138. Innophage Company Detail

Table 139. Innophage Business Overview

Table 140. Innophage Phage Therapy Product

Table 141. Innophage Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 142. Innophage Recent Development

Table 143. Adaptive Phage Therapeutics Company Detail

Table 144. Adaptive Phage Therapeutics Business Overview

Table 145. Adaptive Phage Therapeutics Phage Therapy Product

Table 146. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 147. Adaptive Phage Therapeutics Recent Development

Table 148. TechnoPhage Company Detail

Table 149. TechnoPhage Business Overview

Table 150. TechnoPhage Phage Therapy Product

Table 151. TechnoPhage Revenue in Phage Therapy Business (2019-2024) & (US$ Million)

Table 152. TechnoPhage Recent Development

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Phage Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Phage Therapy Market Share by Type: 2023 VS 2030

Figure 3. DsDNA Bacteriophage Features

Figure 4. SsDNA Bacteriophage Features

Figure 5. SsRNA Bacteriophage Features

Figure 6. Others Features

Figure 7. Global Phage Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Phage Therapy Market Share by Application: 2023 VS 2030

Figure 9. Animal Health Case Studies

Figure 10. Aquaculture Case Studies

Figure 11. Agriculture Case Studies

Figure 12. Food Industry Case Studies

Figure 13. Human Health Case Studies

Figure 14. Others Case Studies

Figure 15. Phage Therapy Report Years Considered

Figure 16. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 17. Global Phage Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Phage Therapy Market Share by Region: 2023 VS 2030

Figure 19. Global Phage Therapy Market Share by Players in 2023

Figure 20. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2023)

Figure 21. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2023

Figure 22. North America Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. North America Phage Therapy Market Share by Country (2019-2030)

Figure 24. United States Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Phage Therapy Market Share by Country (2019-2030)

Figure 28. Germany Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Phage Therapy Market Share by Region (2019-2030)

Figure 36. China Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Japan Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. South Korea Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. India Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Australia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Phage Therapy Market Share by Country (2019-2030)

Figure 44. Mexico Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Brazil Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Phage Therapy Market Share by Country (2019-2030)

Figure 48. Turkey Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Phage Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 51. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 52. Phagelux Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 53. Intralytix Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 54. Micreos Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 55. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 56. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 57. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 58. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 59. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 60. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 61. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 62. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 63. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 64. MicroMir Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 65. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 66. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 67. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 68. Innophage Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 69. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 70. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Phage Therapy Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-37B12844

Global Phage Therapy Market Research Report 2024

FEATURED COMPANIES

Phage Therapy Market Size

Phage Therapy Market

Report Scope

Scope of Phage Therapy Market Report

Chapter Outline

FAQ for this report

How fast is Phage Therapy Market growing?

What is the Phage Therapy Market size in 2030?

What is the market share of major companies in Phage Therapy Market?

What is the Phage Therapy Market share by type?

What is the Phage Therapy Market share by application?

Who are the main players in the Phage Therapy Market report?

What are the Application segmentation covered in the Phage Therapy Market report?

What are the Type segmentation covered in the Phage Therapy Market report?

FEATURED COMPANIES